BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37673973)

  • 21. Comparison of blast percentage calculated based on bone marrow all nucleated cells and non-erythroid cells in myelodysplastic syndromes with erythroid hyperplasia.
    Mashima K; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Umino K; Minakata D; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Ishihara Y; Ashizawa M; Yamamoto C; Fujiwara SI; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Ann Hematol; 2019 May; 98(5):1127-1133. PubMed ID: 30474718
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of TNF receptors and related signaling molecules in the bone marrow from patients with myelodysplastic syndromes.
    Sawanobori M; Yamaguchi S; Hasegawa M; Inoue M; Suzuki K; Kamiyama R; Hirokawa K; Kitagawa M
    Leuk Res; 2003 Jul; 27(7):583-91. PubMed ID: 12681357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes.
    Zaninoni A; Imperiali FG; Cattaneo A; Soverini G; Binda F; Porretti L; Cortelezzi A; Barcellini W
    Transfusion; 2016 Aug; 56(8):2037-41. PubMed ID: 27232106
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Differentiation and expression of membrane hemopoietic cytokine receptors on CD34+ bone marrow cells in patients with myelodysplastic syndromes].
    Li LJ; Fu R; Wang HQ; Yue LZ; Liu H; Wang J; Wang HL; Ruan EB; Qu W; Liang Y; Wang GJ; Wang XM; Liu H; Song J; Wu YH; Xing LM; Guan J; Shao ZH
    Zhonghua Yi Xue Za Zhi; 2011 Jan; 91(4):234-8. PubMed ID: 21418866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunoexpression of 5-methylcytosine (5mc) in Bone Marrow Haematopoietic Cells in Patients with Myelodysplastic Syndromes.
    Sučić M; Ljubić N; Krmek DŽ; Perković L; Ivanović D; Magazin M; Solomun GF
    Ann Clin Lab Sci; 2019 Nov; 49(6):810-817. PubMed ID: 31882433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling.
    Bhagat TD; Zhou L; Sokol L; Kessel R; Caceres G; Gundabolu K; Tamari R; Gordon S; Mantzaris I; Jodlowski T; Yu Y; Jing X; Polineni R; Bhatia K; Pellagatti A; Boultwood J; Kambhampati S; Steidl U; Stein C; Ju W; Liu G; Kenny P; List A; Bitzer M; Verma A
    Blood; 2013 Apr; 121(15):2875-81. PubMed ID: 23390194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays.
    Lee YT; Miller LD; Gubin AN; Makhlouf F; Wojda U; Barrett AJ; Liu ET; Miller JL
    Blood; 2001 Sep; 98(6):1914-21. PubMed ID: 11535529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bone marrow cells from myelodysplastic syndromes show altered immunophenotypic profiles that may contribute to the diagnosis and prognostic stratification of the disease: a pilot study on a series of 56 patients.
    Matarraz S; López A; Barrena S; Fernandez C; Jensen E; Flores-Montero J; Rasillo A; Sayagues JM; Sánchez ML; Bárcena P; Hernandez-Rivas JM; Salvador C; Fernandez-Mosteirín N; Giralt M; Perdiguer L; Laranjeira P; Paiva A; Orfao A
    Cytometry B Clin Cytom; 2010 May; 78(3):154-68. PubMed ID: 20198685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High erythroferrone expression in CD71
    Riabov V; Mossner M; Stöhr A; Jann JC; Streuer A; Schmitt N; Knaflic A; Nowak V; Weimer N; Obländer J; Palme I; Schumann C; Baldus CD; Schulze TJ; Wuchter P; Röhl H; Jawhar A; Weiss C; Boch T; Metzgeroth G; Neumann M; Hofmann WK; Nolte F; Nowak D
    Br J Haematol; 2021 Mar; 192(5):879-891. PubMed ID: 33486765
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncogenic
    Osswald L; Hamarsheh S; Uhl FM; Andrieux G; Klein C; Dierks C; Duquesne S; Braun LM; Schmitt-Graeff A; Duyster J; Boerries M; Brummer T; Zeiser R
    Mol Cancer Res; 2021 Sep; 19(9):1596-1608. PubMed ID: 34088868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vascular endothelial cell growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes.
    Bellamy WT; Richter L; Sirjani D; Roxas C; Glinsmann-Gibson B; Frutiger Y; Grogan TM; List AF
    Blood; 2001 Mar; 97(5):1427-34. PubMed ID: 11222390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BCL-2 Inhibitor ABT-737 Effectively Targets Leukemia-Initiating Cells with Differential Regulation of Relevant Genes Leading to Extended Survival in a NRAS/BCL-2 Mouse Model of High Risk-Myelodysplastic Syndrome.
    Gorombei P; Guidez F; Ganesan S; Chiquet M; Pellagatti A; Goursaud L; Tekin N; Beurlet S; Patel S; Guerenne L; Le Pogam C; Setterblad N; de la Grange P; LeBoeuf C; Janin A; Noguera ME; Sarda-Mantel L; Merlet P; Boultwood J; Konopleva M; Andreeff M; West R; Pla M; Adès L; Fenaux P; Krief P; Chomienne C; Omidvar N; Padua RA
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome.
    Jiang H; Fu R; Wang H; Li L; Liu H; Shao Z
    Leuk Res; 2013 Aug; 37(8):907-10. PubMed ID: 23642736
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired Mitophagy of Nucleated Erythroid Cells Leads to Anemia in Patients with Myelodysplastic Syndromes.
    Jiang H; Yang L; Guo L; Cui N; Zhang G; Liu C; Xing L; Shao Z; Wang H
    Oxid Med Cell Longev; 2018; 2018():6328051. PubMed ID: 29967662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative multi-color flow cytometric analysis of cell surface antigens in bone marrow hematopoietic progenitors between refractory anemia and aplastic anemia.
    Otawa M; Kawanishi Y; Iwase O; Shoji N; Miyazawa K; Ohyashiki K
    Leuk Res; 2000 Apr; 24(4):359-66. PubMed ID: 10713334
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Re-evaluation of classification of myelodysplastic syndromes with low percentage bone marrow blasts].
    Yu MH; Xu ZF; Li L; Nie L; Liu L; Zhang Y; Qin TJ; Hao YS; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jan; 30(1):3-7. PubMed ID: 19563026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abnormal WT1 expression in the CD34-negative compartment in myelodysplastic bone marrow.
    Van Dijk JP; Knops GH; Van De Locht LT; Menke AL; Jansen JH; Mensink EJ; Raymakers RA; De Witte T
    Br J Haematol; 2002 Sep; 118(4):1027-33. PubMed ID: 12199781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of YB-1 gene in erythroid cells in patients with refractory anemia.
    Yokoyama H; Harigae H; Takahashi S; Kameoka J; Miyamura K; Ishizawa K; Kaku M; Sasaki T
    Int J Hematol; 2003 Oct; 78(3):213-8. PubMed ID: 14604279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.
    Sundaravel S; Duggan R; Bhagat T; Ebenezer DL; Liu H; Yu Y; Bartenstein M; Unnikrishnan M; Karmakar S; Liu TC; Torregroza I; Quenon T; Anastasi J; McGraw KL; Pellagatti A; Boultwood J; Yajnik V; Artz A; Le Beau MM; Steidl U; List AF; Evans T; Verma A; Wickrema A
    Proc Natl Acad Sci U S A; 2015 Nov; 112(46):E6359-68. PubMed ID: 26578796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCL12+ stromal cells as bone marrow niche for CD34+ hematopoietic cells and their association with disease progression in myelodysplastic syndromes.
    Abe-Suzuki S; Kurata M; Abe S; Onishi I; Kirimura S; Nashimoto M; Murayama T; Hidaka M; Kitagawa M
    Lab Invest; 2014 Nov; 94(11):1212-23. PubMed ID: 25199050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.